WideMed is a leading company in the growing bio-medical signal diagnostics and treatment market. Leveraging its innovative signal processing algorithms, the company offers comprehensive signal analysis and workflow management services and solutions to the fast growing Cardio-Sleep market.

 

Clinical Sleep Information System

Drug Research Sleep Monitoring

Morpheus® WideMed’s flagship product - the first FDA-approved computer-aided scoring solution. Morpheus is highly recognized by hundreds of physicians around the United States for cardio-sleep analysis and data management. Users of Morpheus software and services receive valuable and timely clinical information, enabling them to provide improved patient treatment, while increasing their operational efficiency and maximizing growth potential.

Sleep monitoring has become a standard for sleep disorders drug development. Morpheus provides innovative sleep quality parameters utilizing its advanced spectral analysis technologies enabling pharmaceutical companies a better insight into pharmaceutical effects of drugs. The advanced data management features allow pharmaceutical companies to perform sleep studies while controlling the data base, reducing cost, and enhancing efficiency.

 

Inpatient Sleep Monitoring

Cardiovascular Diagnostics & Disease Management

 WideMed’s Noga software is an FDA cleared inpatient sleep monitoring and analysis solution that enables the diagnosis of sleep disorders, using a physiological activity monitoring device. By offering inpatient sleep monitoring, WideMed's solution enables sleep study analysis during hospital admission, thus providing additional valuable clinical information on co-morbidity conditions.

Contact us to learn more

WideMed’s extensive research of physiological signals during sleep has shown that sleep-time is the most appropriate timeframe for patient cardiac evaluation and disease management. WideMed is developing an advanced physiological monitoring solution that will provide cardiovascular diagnostics by a breakthrough marker for Heart Failure (HF) disease monitoring. This innovative solution will enable the enhancement of patient care while reducing treatment costs dramatically. Contact us to learn more

 

* Morpheus is a registered trademark of WideMed Ltd.